Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 29Recruiting 11Terminated 9Unknown 5Withdrawn 4Active not recruiting 1

Sponsor Class

OTHER 26INDUSTRY 4OTHER_GOV 1NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Papillomavirus Infections 1Opioid-Related Disorders 1Neoplastic Cells, Circulating 1Lymphoma, Follicular 1Barrett Esophagus 1

Interventions

Paclitaxel 31Cyclophosphamide 30Cisplatin 29Bevacizumab 28Carboplatin 27Fluorouracil 24pembrolizumab 21Nivolumab 21Leucovorin 20Rituximab 19avelumab 18Gemcitabine 18Docetaxel 18Dexamethasone 18Capecitabine 17ALT-803 15130-nm albumin-bound paclitaxel 14Oxaliplatin 12Cetuximab 12fludarabine 11Ipilimumab 11venetoclax 10atezolizumab 10Radiosurgery 10Radiotherapy 9Pemetrexed 9Omacor 9Lenalidomide 9Bendamustine Hydrochloride 9yeast-CEA vaccine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × INDUSTRY × Blood Specimen Collection × Clear all
NCT05251376 2023-01-19

Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy

Lyndra Inc.

Phase 1 Withdrawn
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT02742259 2019-03-26

VPCA-B+PIV

Celsee Diagnostics

Withdrawn
Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT02100618 2015-07-20

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

GlaxoSmithKline

Phase 3 Withdrawn

Papillomavirus Infections

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡